کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
10969820 | 1102993 | 2011 | 7 صفحه PDF | دانلود رایگان |
عنوان انگلیسی مقاله ISI
Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial
دانلود مقاله + سفارش ترجمه
دانلود مقاله ISI انگلیسی
رایگان برای ایرانیان
کلمات کلیدی
موضوعات مرتبط
علوم زیستی و بیوفناوری
ایمنی شناسی و میکروب شناسی
ایمونولوژی
پیش نمایش صفحه اول مقاله
![عکس صفحه اول مقاله: Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial Protective efficacy of a trivalent recombinant hemagglutinin protein vaccine (FluBlok®) against influenza in healthy adults: A randomized, placebo-controlled trial](/preview/png/10969820.png)
چکیده انگلیسی
⺠Randomized, placebo-controlled, multicenter assessment of efficacy of baculovirus expressed hemagglutinin vaccine for prevention of laboratory-documented influenza illness in healthy adults. ⺠Vaccine was safe and generated serum hemagglutination-inhibiting antibody responses against all three components in the majority of recipients. ⺠Influenza infections during surveillance were antigenically mismatched to the components in the vaccine. ⺠Vaccine efficacy was 44.8% (95% CI, 24.4%, 60.0%) for prevention of preventing culture-confirmed influenza illness.
ناشر
Database: Elsevier - ScienceDirect (ساینس دایرکت)
Journal: Vaccine - Volume 29, Issue 44, 13 October 2011, Pages 7733-7739
Journal: Vaccine - Volume 29, Issue 44, 13 October 2011, Pages 7733-7739
نویسندگان
John J. Treanor, Hana El Sahly, James King, Irene Graham, Ruvim Izikson, Robert Kohberger, Peter Patriarca, Manon Cox,